Member Info for Soupdragon78

On a slightly more thoughtful note... the optimist in me would say that I think the NXP004 tests should be coming in soon, we know they kicked off in May, so four months is a good chunk of time to have got something out of them (the non-scientist in me knowing nothing about likely timescales or what they are actually doing.)

As longs as Brindley doesn't turn around and say 'Four-Q'

See what I did there....
I'll get me coat.

Happy days for the two quid buyer, he's getting 6 more shares for his shiny two pound coin than he was at the start of the week.

Such a Jammy dodger.

And just to add the connection of Dr Robin Bannister of Biocopea and Dr Julian Gilbert of NFX.

Together they found Arakis in 2000, which they then sold to Sosei in 2006.

Oxilio have a contract with Biocopea.

Biocopea are owned by PeptCell who spin out companies for different for different opportunities, Valiseek was the third spin out by them. This is a SPV and part of the joint venture with ValiRx and Tangent Reprofiling (also Peptcell owned)

https://www.valirx.com/our-subsidiaries

http://seekacure.com/

Good connection there FX, not sure if you know, but VAL are part of the same group that have a contract with Oxilio.

“ As previously disclosed, we are expecting important readouts on the progress with NXP002 and NXP004 later in 2021 and positive outcomes on these will trigger licensing discussions with key players.”

Riddell was quite categorical in his letter to shareholders. Makes you wonder who the ‘key players’ are?

Thank you for your explanation Loki.

Best.

Never fear FX, the £2 buyer has our backs.

Older, I've never had an issue here with trades showing, its probably because you're not a paid subscriber.

The simply Wall Street site has an updated shareholder list now, dated 2 Aug. again can’t vouch for its accuracy but Higgins and Chorlton have dropped off its list since the previous update.

https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-nfx/nuformix-shares#ownership

27-Sep-21 17:06:26 1.325 2,800,000 Unknown* 37.10k O

Now got a 2.8m showing up at 1.325p after hours. All adds to the fun.

" This would mean that there can be no significant information released for approx 2 months...."

Not quite true.

There can be significant information released if it is something that was not known at the time of the director purchase.

If a bid for the company or asset came that wasn't being negotiated at the time of his buy then this would be released.
If their outsourced CRO reported back with positive news that was not expected, then this would be released.

Maybe DT is clearing out to scrabble some cash together, he's only got 2 days left to sort out the Ebers RTO into Kelly Ventures before it falls through.

I guess they couldn't hang on for Q4.

Filter, I'm going by the assumption that the 18m trade was someone who took part in the placing selling up, they probably never notified to start with anyway.

Looks like SCAP can't be bothered turning their terminal on today, slightly odd.

I guess the company should update their timeline which has inhaler feasibility completing in Q3.

Good to have confirmation that the company has cash through to March 2023.

The two quid buyer is happy its back in his zone again! Booyah!